Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
J Dairy Sci ; 100(9): 7026-7034, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28711259

ABSTRACT

pH is one of the most important parameters to manage bacterial replication in foodstuffs. In this study, the ability of 2 Bacillus cereus strains, 1 clinical human isolate (GPe2) and 1 isolate from a dairy product (D43), were investigated for in vitro growth at different pH values (from 3.5 to 7.5) at 2 temperatures (15 and 37°C), showing their ability to grow from 5.5 to 7.5 and from 5.0 to 7.5, respectively. The ability of spores of these 2 microorganisms to germinate in different typologies of dairy products (unflavored yogurt, Taleggio cheese, mascarpone cheese, and raw and pasteurized milk) was also investigated by inoculating the spores and maintaining the products at 15°C. No growth was observed in yogurt, likely due to the combined effect of low pH (<5) and the presence of natural microflora. An inhibitory action of the natural microflora on the growth of B. cereus was also hypothesized for Taleggio cheese and raw milk, as these substrates were characterized by a high natural lactic acid bacteria population and permissive pH values (5.8/6.8 in Taleggio cheese, >7 in raw milk). In pasteurized milk and mascarpone cheese, where pH was not restrictive for B. cereus growth and where no significant natural microflora was present, growth occurred rapidly up to loads close to 7 log cfu/g.


Subject(s)
Bacillus cereus/growth & development , Cheese/microbiology , Yogurt/microbiology , Animals , Food Microbiology , Humans , Hydrogen-Ion Concentration , Milk/microbiology , Temperature
2.
Eur J Clin Microbiol Infect Dis ; 36(10): 1739-1748, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28470337

ABSTRACT

The spread of multi-drug resistant (MDR) Klebsiella pneumoniae strains producing carbapenemases points to a pressing need for new antibacterial agents. To this end, the in-vitro antibacterial activity of a synthetic N-terminal peptide of human lactoferrin, further referred to as hLF1-11, was evaluated against K. pneumoniae strains harboring different carbapenemase genes (i.e. OXA-48, KPC-2, KPC-3, VIM-1), with different susceptibility to colistin and other antibiotics, alone or in combination with conventional antibiotics (gentamicin, tigecycline, rifampicin, clindamycin, and clarithromycin). An antimicrobial peptide susceptibility assay was used to assess the bactericidal activity of hLF1-11 against the different K. pneumoniae strains tested. The synergistic activity was evaluated by a checkerboard titration method, and the fractional inhibitory concentration (FIC) index was calculated for the various combinations. hLF1-11 was more efficient in killing a K. pneumoniae strain susceptible to most antimicrobials (including colistin) than a colistin-susceptible strain and a colistin-resistant MDR K. pneumoniae strain. In addition, hLF1-11 exhibited a synergistic effect with the tested antibiotics against MDR K. pneumoniae strains. The results of this study indicate that resistance to hLF1-11 and colistin are not strictly associated, and suggest an hLF1-11-induced sensitizing effect of K. pneumoniae to antibiotics, especially to hydrophobic antibiotics, which are normally not effective on Gram-negative bacteria. Altogether, these data indicate that hLF1-11 in combination with antibiotics is a promising candidate to treat infections caused by MDR-K. pneumoniae strains.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenem-Resistant Enterobacteriaceae/drug effects , Drug Synergism , Klebsiella pneumoniae/drug effects , Lactoferrin/pharmacology , Peptides/pharmacology , Bacterial Proteins/genetics , Carbapenem-Resistant Enterobacteriaceae/enzymology , Carbapenem-Resistant Enterobacteriaceae/genetics , Humans , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/genetics , Lactoferrin/genetics , Microbial Sensitivity Tests , Peptides/genetics , beta-Lactamases/genetics
3.
J Appl Microbiol ; 119(2): 552-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25973914

ABSTRACT

AIMS: This study aimed to investigate the fate of Bacillus clausii spores orally administered as lyophilized or liquid formulation to healthy volunteers. METHODS AND RESULTS: The study was a randomized, open-label, cross-over trial in which two commercial probiotic formulations containing spores of four antibiotic-resistant B. clausii strains (OC, NR, SIN, T) were given as a single dose administration. Faecal B. clausii units of each strain were counted on selective media and extrapolated for the total weight of evacuated faeces. RAPD-PCR typing was used to confirm B. clausii identification. Bacillus clausii was found alive in faeces for up to 12 days. In some volunteers, the recovered amount of OC, NR or SIN was higher than the number of administered spores. Bioequivalence among the two formulations was demonstrated. CONCLUSIONS: Bacillus clausii spores survive transit through the human gastrointestinal tract. They can undergo germination, outgrowth and multiplication as vegetative forms. Bacillus clausii strains can have different ability to survive in the intestinal environment. Bacillus clausii spores administered as liquid suspension or lyophilized form behave similarly in vivo. SIGNIFICANCE AND IMPACT OF THE STUDY: This work contributes towards a better understanding of the behaviour of B. clausii spores as probiotics.


Subject(s)
Bacillus/growth & development , Gastrointestinal Tract/microbiology , Probiotics/administration & dosage , Administration, Oral , Adult , Bacillus/genetics , Cross-Over Studies , Feces/microbiology , Female , Humans , Male , Random Allocation , Random Amplified Polymorphic DNA Technique , Spores, Bacterial/genetics , Spores, Bacterial/growth & development
4.
Eur J Clin Microbiol Infect Dis ; 32(4): 493-502, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23114724

ABSTRACT

The rapid identification and antimicrobial susceptibility testing (AST) of bacteria in clinical blood cultures is crucial to optimise antimicrobial therapy. A previous study involving small sample numbers revealed that the addition of saponin to blood cultures, further referred to as the new method, shortened considerably the turn-around time for the identification and AST of Gram-positive cocci as compared to the current method involving an overnight subculture. Here, we extend previous results and compare the identification and AST of blood cultures containing Gram-negative bacilli by the new and current methods. The identification and AST of 121 Gram-positive and 109 Gram-negative bacteria in clinical monomicrobial blood cultures by the new and current methods and, in the case of Gram-negative bacilli, by direct (no additions) inoculation into an automated system (rapid method) was assessed using the Vitek 2 system. Discrepancies between the results obtained with the different methods were solved by manual methods. The new method correctly identified 88 % of Gram-positive and 98 % of Gram-negative bacteria, and the rapid method correctly identified 94 % of Gram-negative bacteria. The AST for all antimicrobials by the new method were concordant with the current method for 55 % and correct for an additional 9 % of Gram-positive bacteria, and concordant with the current method for 62 % and correct for an additional 21 % of Gram-negative bacilli. The AST by the rapid method was concordant with the current method for 62 % and correct for an additional 12 % of Gram-negative bacilli. Together, saponin-treated monomicrobial blood cultures allow rapid and reliable identification and AST of Gram-positive and Gram-negative bacteria.


Subject(s)
Bacteremia/diagnosis , Bacterial Typing Techniques/methods , Gram-Negative Bacteria/isolation & purification , Saponins , Specimen Handling/methods , Bacteremia/microbiology , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria , Humans , Microbial Sensitivity Tests/methods , Time Factors
5.
Br J Dermatol ; 162(2): 311-7, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-19886884

ABSTRACT

BACKGROUND: Two nail lacquers, containing ciclopirox (CPX) or amorolfine (MRF), based on water-insoluble polymers are currently considered mainstays of topical treatment of onychomycosis. The present study aimed at evaluating the antimycotic activity of a new water-soluble nail lacquer containing CPX (CPX/sol), easily removable by washing with water and applicable to periungual skin. OBJECTIVES: To compare transungual permeation of CPX with that of MRF in the same hydroxypropyl chitosan-based nail lacquer (MRF/sol) and with a nonwater-soluble reference (Loceryl); Galderma International, La Défense, France), and to evaluate the antimycotic activity of CPX/sol and Loceryl against the most common fungal strains that cause onychomycosis. Methods In vitro drug permeation experiments with CPX/sol, MRF/sol and Loceryl were carried out through bovine hoof slices. Experimental permeates from CPX/sol and Loceryl underwent in vitro susceptibility testing against clinical isolates of dermatophytes, moulds and yeast. Results MRF transungual flux from MRF/sol lacquer was significantly higher when compared with Loceryl. CPX was able to permeate hoof membranes more easily compared with MRF. CPX and MRF concentrations in the subungual fluids collected after application of CPX/sol or Loceryl were sufficient to inhibit fungal growth, with the exception of Candida parapsilosis. Smaller amounts of fluid containing CPX were required for complete inhibition of fungal growth. Efficacy index values were significantly higher for CPX/sol. Conclusions Application of the CPX/sol nail lacquer allows rapid nail penetration of CPX, providing CPX levels sufficient to inhibit fungal growth for a prolonged period of time (30 h) after application of lacquer dose. CPX/sol nail lacquer appeared superior to the market reference Loceryl in terms of both vehicle (hydroxypropyl chitosan) and active ingredient (CPX) as witnessed by its higher efficacy on all nail pathogens.


Subject(s)
Antifungal Agents/administration & dosage , Lacquer , Morpholines/administration & dosage , Onychomycosis/drug therapy , Pyridones/administration & dosage , Absorption , Administration, Topical , Animals , Antifungal Agents/pharmacokinetics , Cattle , Ciclopirox , Hoof and Claw , Humans , Morpholines/pharmacokinetics , Nails , Onychomycosis/metabolism , Permeability , Pharmaceutical Solutions/administration & dosage , Pharmaceutical Vehicles , Pyridones/pharmacokinetics , Regression Analysis , Solubility
6.
Clin Microbiol Infect ; 14(2): 141-7, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17986267

ABSTRACT

Chromogenic Candida Agar is a novel differential culture medium that is claimed to facilitate isolation and identification of Candida albicans, Candida tropicalis and Candida krusei. The performance of this medium was evaluated for presumptive identification of 521 yeast strains, representing 23 different species, for detection of specimens containing yeast mixtures, and for direct isolation of yeast from blood cultures. All yeasts grew well on the medium following a 48-h incubation period at 37 degrees C, and distinctive colonies were produced by C. albicans, C. tropicalis, C. krusei, Candida guilliermondii, Saccharomyces cerevisiae, Trichosporon mucoides and Geotrichum capitatum. The sensitivity and specificity of the medium exceeded 99.4% for each of these species. The medium provided some indication of the presence of Candida dubliniensis and Candida pulcherrima, and allowed the identification of polyfungal samples in 89.4% of the yeast mixtures. Finally, direct isolation on the medium from blood cultures that were positive for yeast according to Gram's stain (n = 42) showed that the expected colour and morphology of each species were not altered in the presence of blood.


Subject(s)
Chromogenic Compounds , Mycological Typing Techniques/standards , Mycoses/microbiology , Yeasts/classification , Agar , Blood/microbiology , Culture Media , Humans , Mycological Typing Techniques/methods , Mycoses/diagnosis , Sensitivity and Specificity , Species Specificity , Yeasts/isolation & purification
7.
J Appl Microbiol ; 97(6): 1220-7, 2004.
Article in English | MEDLINE | ID: mdl-15546413

ABSTRACT

AIMS: To compare the killing efficacy and the effects exerted by microwaves and conventional heating on structural and molecular components of Bacillus subtilis spores. METHODS AND RESULTS: A microwave waveguide applicator was developed to generate a uniform and measurable distribution of the microwave electric-field amplitude. The applicator enabled the killing efficacy exerted by microwaves on B. subtilis spores to be evaluated in comparison with conventional heating at the same temperature value. The two treatments produced a similar kinetics of spore survival, while remarkably different effects on spore structures were seen. The cortex layer of the spores subjected to conductive heating was 10 times wider than that of the untreated spores; in contrast, the cortex of irradiated spores did not change. In addition, the heated spores were found to release appreciable amounts of dipicolinic acid (DPA) upon treatment, while extracellular DPA was completely undetectable in supernatants of the irradiated spores. These observations suggest that microwave radiation may promote the formation of stable complexes between DPA and other spore components (i.e. calcium ions); thus, making any release of DPA from irradiated spores undetectable. Indeed, while a decrease in measurable DPA concentrations was not produced by microwave radiation on pure DPA solutions, a significant lowering in DPA concentration was detected when this molecule was exposed to microwaves in the presence of either calcium ions or spore suspensions. CONCLUSIONS: Microwaves are as effective as conductive heating in killing B. subtilis spores, but the microwave E-field induces changes in the structural and/or molecular components of spores that differ from those attributable only to heat. SIGNIFICANCE AND IMPACT OF THE STUDY: This study provides information on the effect of microwaves on B. subtilis spore components.


Subject(s)
Bacillus subtilis/radiation effects , Microwaves , Spores, Fungal/radiation effects , Bacillus subtilis/metabolism , Bacillus subtilis/ultrastructure , Calcium/metabolism , Enzyme Inhibitors/metabolism , Hot Temperature , Microscopy, Electron , Picolinic Acids/metabolism , Spores, Fungal/metabolism , Spores, Fungal/ultrastructure
8.
J Appl Microbiol ; 95(6): 1255-60, 2003.
Article in English | MEDLINE | ID: mdl-14632999

ABSTRACT

AIMS: Development of an agar-diffusion assay to measure vitamin B2 in biological samples and application of the method to determine the amount of vitamin B2 secreted by bacteria. METHODS AND RESULTS: A riboflavin-auxotrophic mutant of Bacillus cereus was generated by mini-Tn10 insertion in the ribD gene. ribD mutant sensitivity to exogenous vitamin B2 was investigated by turbidimetric and agar-diffusion assays. In turbidimetric assays, the B. cereus mutant displayed a similar level of sensitivity to vitamin B2 to that of Lactobacillus casei ATCC 7469, the reference organism used for microbiological vitamin B2 quantification. However, only the ribD mutant could be used as an indicator organism in agar-diffusion assays. A total of eight probiotic strains, from five different probiotic formulations, were analysed by the ribD mutant-based assay on agar plates in order to determine their ability to secrete vitamin B2 during growth. CONCLUSION: The agar diffusion method with the ribD mutant of B. cereus is highly reproducible, sensitive, rapid, inexpensive, and can be applied to measure the amount of vitamin B2 in different samples. SIGNIFICANCE AND IMPACT OF THE STUDY: The method developed in this study appears to be a good candidate for the screening of vitamin B2 secretion by bacteria growing on solid media.


Subject(s)
Bacillus cereus/metabolism , Probiotics/metabolism , Riboflavin/metabolism , Agar , Bacillus cereus/drug effects , Bacillus cereus/genetics , Bacillus cereus/growth & development , Bacteriological Techniques/methods , Culture Media , Dose-Response Relationship, Drug , Microbial Sensitivity Tests/methods , Mutagenesis, Insertional , Nephelometry and Turbidimetry , Riboflavin/genetics , Riboflavin/pharmacology
9.
J Periodontol ; 72(9): 1151-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11577945

ABSTRACT

BACKGROUND: Non-steroidal anti-inflammatory drugs and antibiotics are important in the prevention of infections and pain associated with periodontal surgery as well as in the adjunctive therapy of periodontal disease. In this study, patients undergoing oral surgery were treated with piroxicam and azithromycin to examine the interactions of these drugs on periodontal tissues. METHODS: Sixty-six patients were assigned to 3 groups and treated for 3 days as follows: 1) piroxicam 20 mg/day; 2) azithromycin 500 mg/day; or 3) piroxicam 20 mg/day plus azithromycin 500 mg/day. Samples of blood, saliva, gingiva, and alveolar bone were collected during surgery and at days 0.5, 2.5, 4.5, and 6.5 after last dose. Piroxicam concentrations were assayed by high-performance liquid chromatography and azithromycin concentrations by microbiological assay. RESULTS: In patients treated with piroxicam alone, the highest drug concentrations were found in plasma at each time point, but consistent piroxicam levels were also detected in gingival samples up to 4.5 days. The combined treatment with piroxicam plus azithromycin was associated with a reduction of piroxicam concentrations in periodontal tissues. In patients receiving azithromycin alone, high drug levels were measured in periodontal tissues up to 6.5 days. This distribution pattern did not vary in patients treated with piroxicam plus azithromycin. CONCLUSIONS: Treatment with piroxicam or azithromycin alone ensures a favorable distribution of these drugs into periodontal tissues. However, upon combined administration, azithromycin interferes negatively with the periodontal disposition of piroxicam. This interaction might depend on the displacement of piroxicam from acceptor sites at the level of periodontal tissues.


Subject(s)
Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/pharmacokinetics , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Azithromycin/adverse effects , Azithromycin/pharmacokinetics , Piroxicam/pharmacokinetics , Adolescent , Adult , Anti-Bacterial Agents/blood , Anti-Inflammatory Agents, Non-Steroidal/blood , Azithromycin/blood , Drug Combinations , Drug Interactions , Female , Humans , Male , Middle Aged , Periodontium/metabolism , Piroxicam/blood , Saliva/metabolism , Time Factors , Tissue Distribution
10.
Eur J Clin Microbiol Infect Dis ; 20(8): 544-53, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11681433

ABSTRACT

This report describes the use of the 27A probe for the molecular monitoring of Candida albicans infections in liver transplant recipients. Nosocomial candidiasis is the major fungal infection in liver transplant recipients, with Candida albicans being the species most frequently isolated. The molecular epidemiology of Candida albicans infections has been widely investigated, but scant attention has been focused on monitoring the identity of infecting strains in individual patients over the entire course of their hospitalization. In the study presented here, a total of 179 Candida albicans isolates were collected from 10 liver transplant recipients during multiple surveillance cultures performed before and after liver transplantation and from three healthcare workers at the Transplant Unit of Ospedale di Cisanello, Pisa (Italy). Computer-aided analysis of the 27A-probed DNA fingerprints, used to compare the genetic relatedness of all the Candida albicans isolates, showed that most of the patients colonized with Candida albicans before transplantation harbored a unique Candida albicans genotype. This genotype persisted over the entire course of hospitalization and caused multiorgan failure in two patients, both of whom died from endogenously borne Candida albicans infections. Nosocomial acquisition of Candida albicans strains could be monitored in a timely manner in the other patients; for some of them, subsequent strain replacement was registered at different body sites during the post-transplant period. Neither cross-infection between patients nor transmission from healthcare workers to patients occurred in this hospital setting. These results indicate that the molecular monitoring of Candida albicans strains isolated from liver transplant recipients during their hospitalization may provide timely information about the identity of individual Candida albicans strains causing infections.


Subject(s)
Candida albicans/classification , Candida albicans/genetics , Candidiasis/microbiology , DNA Probes/genetics , Liver Transplantation/adverse effects , Adult , Aged , Blotting, Southern , Candida albicans/isolation & purification , Candidiasis/diagnosis , DNA Fingerprinting/methods , Digoxigenin/metabolism , Female , Humans , Male , Middle Aged , Species Specificity
11.
Appl Environ Microbiol ; 67(2): 834-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11157251

ABSTRACT

A substantial number of Bacillus species have been marketed for use in oral bacteriotherapy because of their purported ability to prevent or treat various gastrointestinal disorders. Recently, some of the Bacillus strains in Enterogermina, which is made up of aqueous suspensions of viable Bacillus spores, have been partially characterized and aligned with members of the Bacillus alcalophilus subgroup rather than with Bacillus subtilis, as previously reported. With a view toward verifying the original taxonomic position of the Enterogermina strains, we catalogued both phenotypic and genotypic traits exhibited by the four Bacillus strains isolated from the spore mixtures found in original commercial preparations dated 1975 and 1984 and commercial preparations now being propagated industrially. Analyses of physiological and biochemical traits, complete 16S rRNA gene sequences, DNA-DNA reassociation, tRNA intergenic spacer length polymorphism, single-strand conformation polymorphism of PCR-amplified spacer regions of tRNA genes, and randomly amplified polymorphic DNA led to the finding that all of the Enterogermina strains belong to a unique genospecies, which is unequivocally identified as the alkalitolerant species Bacillus clausii. Moreover, we provide evidence that in contrast to several reference strains of B. clausii, the strains constituting Enterogermina are characterized by a notable low level of intraspecific genome diversity and that each strain has remained the same for the last 25 years.


Subject(s)
Bacillus/classification , Bacillus/genetics , Gastrointestinal Diseases/therapy , Probiotics/therapeutic use , Administration, Oral , Bacterial Typing Techniques , DNA, Bacterial/genetics , Genes, rRNA , Humans , Molecular Sequence Data , Nucleic Acid Hybridization , Phenotype , Polymerase Chain Reaction/methods , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , RNA, Ribosomal, 16S/genetics , RNA, Transfer/genetics , Random Amplified Polymorphic DNA Technique , Spores, Bacterial/growth & development
12.
J Antimicrob Chemother ; 46(5): 831-4, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11062209

ABSTRACT

This report describes the efficacy of a novel mucoadhesive polymer, the tamarind seed polysaccharide, as a delivery system for the ocular administration of hydrophilic and hydrophobic antibiotics. Healthy rabbits were subjected to repeated ocular instillations with either conventional gentamicin or ofloxacin or these agents viscosified with the tamarind seed polysaccharide. Administration of viscosified preparations produced antibiotic concentrations both in the aqueous humour and cornea that were significantly higher than those achieved with the drugs alone. The increased drug absorption and the prolonged drug elimination phase obtained with the viscosified formulations indicate the usefulness of the tamarind seed polysaccharide as an ophthalmic delivery system for topical administration of antibiotics.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Anti-Infective Agents/pharmacokinetics , Aqueous Humor/metabolism , Gentamicins/pharmacokinetics , Glycosaminoglycans/pharmacokinetics , Ofloxacin/pharmacokinetics , Administration, Topical , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Drug Delivery Systems/methods , Drug Interactions , Eye Infections/drug therapy , Gentamicins/therapeutic use , Glycosaminoglycans/therapeutic use , Male , Ofloxacin/therapeutic use , Phytotherapy , Rabbits , Seeds/therapeutic use
13.
FEMS Microbiol Lett ; 190(2): 247-53, 2000 Sep 15.
Article in English | MEDLINE | ID: mdl-11034287

ABSTRACT

This paper describes the first identification of chemotaxis genes in Bacillus cereus. We sequenced and studied the genomic organization and the expression of the cheA and fliY genes in two different B. cereus strains, ATCC 14579 and ATCC 10987. While cheA encodes a highly conserved protein acting as the main regulator of the chemotactic response in flagellated eubacteria, fliY, which has been previously described only in B. subtilis, is one of the three genes encoding proteins of the flagellar switch complex. Although the sequences and relative position of cheA and fliY were found to be identical in the two B. cereus strains analyzed, the restriction fragment containing both genes was located differently on the physical maps of B. cereus ATCC 14579 and ATCC 10987. Evidence is shown that the genomic organization and the expression of fliY and cheA in B. cereus differ significantly from that described for B. subtilis, which is considered a model microorganism for chemotaxis in gram-positive bacteria.


Subject(s)
Bacillus cereus/genetics , Bacillus cereus/physiology , Bacterial Proteins/genetics , Chemotaxis/genetics , Membrane Proteins/genetics , Amino Acid Sequence , Bacterial Proteins/metabolism , Chemotaxis/physiology , DNA, Complementary/genetics , Electrophoresis, Gel, Pulsed-Field , Genomic Library , Membrane Proteins/metabolism , Methyl-Accepting Chemotaxis Proteins , Molecular Sequence Data , Physical Chromosome Mapping , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
14.
Antimicrob Agents Chemother ; 42(9): 2434-6, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9736578

ABSTRACT

The complexation of econazole with the mucoadhesive polycarbophil was found to significantly improve the therapeutic benefit of the drug in the topical treatment of experimental vaginal candidiasis in mice, while no difference in the antimycotic activity exerted by econazole and polycarbophil-econazole could be detected in vitro.


Subject(s)
Acrylic Resins/administration & dosage , Antifungal Agents/administration & dosage , Candidiasis, Vulvovaginal/drug therapy , Econazole/administration & dosage , Administration, Topical , Animals , Female , Mice , Mice, Inbred CBA
15.
J Periodontol ; 68(12): 1206-9, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9444596

ABSTRACT

The tissue penetration of azithromycin, the prototype of a new class of macrolide antibiotics named azalides, was studied in patients undergoing surgery for third-molar removal. Drug concentrations in plasma, saliva, and periodontal tissues were evaluated in 28 patients treated with azithromycin 500 mg/day per os for 3 consecutive days. Samples of blood, saliva, gingiva, and alveolar bone were collected during oral surgery, 12 hours, and 2.5, 4.5, and 6.5 days after the last dosing, and the azithromycin concentration was measured microbiologically by using Micrococcus luteus NCTC 8440 as the reference organism. The highest concentrations of azithromycin were observed 12 hours after the last dose in plasma, saliva, gingiva, and bone (0.33 +/- 0.04 mg/l, 2.14 +/- 0.30 mg/l, 6.47 +/- 0.57 mg/kg, and 1.86 +/- 0.15 mg/kg, respectively) and then declined gradually. However, consistent levels of the drug in saliva and periodontal tissues could be detected up to 6.5 days, indicating that azithromycin was retained in target tissues and fluids for a long time after the end of treatment. Among the samples examined, the highest concentration of azithromycin was found in the gingiva at each time studied. Moreover, the ratios of salivary or periodontal tissue levels versus plasma concentrations remained nearly unmodified from 12 hours up to 6.5 days. Overall, these results indicate a favorable disposition of azithromycin into saliva and periodontal tissues and suggest that this macrolide antibiotic represents a valuable option in the pharmacologic treatment of odontogenic infections.


Subject(s)
Anti-Bacterial Agents/pharmacokinetics , Azithromycin/pharmacokinetics , Periodontium/metabolism , Adult , Alveolar Process/metabolism , Analysis of Variance , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/analysis , Anti-Bacterial Agents/blood , Azithromycin/administration & dosage , Azithromycin/analysis , Azithromycin/blood , Female , Follow-Up Studies , Gingiva/metabolism , Humans , Male , Micrococcus luteus/drug effects , Molar, Third/surgery , Saliva/chemistry , Time Factors , Tissue Distribution , Tooth Extraction
16.
Immunol Lett ; 53(1): 31-9, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8946215

ABSTRACT

A vesicular stomatitis virus glycoprotein-specific, class II restricted, CD4+ T-cell clone was obtained and the unidentified T-cell receptor alpha chain cloned in order to establish a T-cell receptor (TCR) alpha chain transgenic mouse line. Polymerase chain reaction (PCR) strategies have been developed to clone TCR chain genes starting from T-cell cDNA. There remain difficulties, however, in cloning the functional TCR alpha chain due to the complexity of the protocols applied if the variable (V) alpha region rearranged is not known. The strategy described here allows the identification and cloning of alpha chains that are not recognized by any of the anti-V alpha monoclonal antibodies available: three 5' consensus V alpha primers designed from all known V alpha gene sequences and a primer specific for the constant (C) alpha region were used and the PCR product sequenced. The T-cell clone displayed two alpha gene rearrangements, only one of which giving rise to a functional protein. The alpha chain used by the T-cell clone contained a V alpha 3.1 and a J alpha region which has been described only at the genomic level, but never in a functional TCR. The complete alpha chain gene was cloned by enriching the alpha chain-encoding cDNA by ligation-anchored PCR and using an alpha specific primer pair. The use of the present method, even if the sequence of the 5' untranslated (UT) region of the alpha chain is not known, is also discussed.


Subject(s)
Membrane Glycoproteins , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes, Helper-Inducer/immunology , Vesicular stomatitis Indiana virus/immunology , Viral Envelope Proteins/immunology , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Clone Cells , Cloning, Molecular , Cricetinae , DNA , Genes , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Receptors, Antigen, T-Cell, alpha-beta/immunology , T-Lymphocytes, Helper-Inducer/cytology
17.
Eur J Immunol ; 25(5): 1410-6, 1995 May.
Article in English | MEDLINE | ID: mdl-7539759

ABSTRACT

During most immune responses, T cells help antigen-specific B cells to make antibodies against the antigen. One of the contributions of T cells to antibody production is the induction of isotype switching from IgM to IgG, which is the most abundant isotype in blood serum during recall responses. Other features of memory responses are faster kinetics and higher titers of antibody in the serum. What causes a primary immune response to be different from a secondary is not yet very clear and, particularly, the influence of precursor frequencies of T and B cells on memory responses still remains to be answered. To address this issue, a transgenic (tg) mouse line (ADA) was developed; it expresses the beta chain (V beta 2) of a major histocompatibility complex class II-restricted T cell receptor (TcR) specific for the glycoprotein (G) of vesicular stomatitis virus (VSV) serotype Indiana (VSV-IND). These mice exhibit an increased precursor frequency of VSV-specific CD4+ T cells that leads to enhanced neutralizing IgG production against VSV in vivo in unprimed mice. The data indicate that increased frequency of naive specific helper T cells alone may account for features of a memory phenotype such as high titer of antibodies and isotype switching.


Subject(s)
Antibodies, Viral/biosynthesis , Immunologic Memory , Lymphocyte Cooperation , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes, Helper-Inducer/immunology , Vesicular stomatitis Indiana virus/immunology , Amino Acid Sequence , Animals , Antibodies, Viral/immunology , Base Sequence , Cells, Cultured , Epitopes/immunology , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor , Hematopoietic Stem Cells/immunology , Immunoglobulin Class Switching , Immunoglobulin G/biosynthesis , Immunoglobulin G/immunology , Immunoglobulin M/biosynthesis , Immunoglobulin M/immunology , Lymphocyte Count , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Neutralization Tests , Receptors, Antigen, T-Cell, alpha-beta/immunology , Spleen/cytology
18.
J Wildl Dis ; 31(1): 70-4, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7563428

ABSTRACT

In May 1991, clinical, pathologic, and virologic investigations were carried out on an 8-yr-old male lion (Panthera leo), with recurrent infections, in captivity with two lionesses in the Zoological Garden of Pistoia, Tuscany, Italy. The lion had severe pneumonia, neutropenia, thrombocytopenia, and an increase in blood urea nitrogen and creatininemia; in spite of therapy, it died within 3 months. At necropsy, the animal had a lymphoma and other lesions similar to those described in feline immunodeficiency virus-infected cats. We identified FIV gag-sequence using PCR amplification of lymph node tissues.


Subject(s)
Feline Acquired Immunodeficiency Syndrome , Immunodeficiency Virus, Feline/immunology , Lentivirus Infections/veterinary , Lions , Animals , Animals, Zoo , Antibodies, Viral/blood , Antigens, Viral/immunology , Blood Urea Nitrogen , Blotting, Southern/veterinary , Blotting, Western/veterinary , Coronavirus, Feline/immunology , Creatinine/blood , DNA, Viral/analysis , Feline Acquired Immunodeficiency Syndrome/complications , Feline Acquired Immunodeficiency Syndrome/virology , Gene Products, gag/genetics , Immunodeficiency Virus, Feline/genetics , Lentivirus Infections/complications , Lentivirus Infections/virology , Leukemia Virus, Feline/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/etiology , Leukemia, Lymphocytic, Chronic, B-Cell/veterinary , Lymph Nodes/pathology , Lymph Nodes/virology , Male , Neutropenia/etiology , Neutropenia/veterinary , Pneumonia, Pneumococcal/etiology , Pneumonia, Pneumococcal/veterinary , Polymerase Chain Reaction/veterinary , Thrombocytopenia/etiology , Thrombocytopenia/veterinary
19.
Eur J Epidemiol ; 9(5): 483-8, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8307132

ABSTRACT

The aim of this investigation was to gain further insight into the prevalence of different serotypes of mutans streptococci in the Italian population by using specific monoclonal antibodies in an enzyme immunoassay. Isolates from dental plaque samples, collected from an adult population living in Pisa (Italy), were identified as mutans streptococci on the basis of their morphological and biochemical properties, and were then serotyped. The results show that 77.5% of the strains isolated belonged to serotype c or f (i.e., S. mutans), 15.9% were serotype e (i.e., S. mutans) and only two strains (1.4%) belonged to serotype g (i.e., S. sobrinus). These data are partially in agreement with other studies in Europe and in the U.S.A. The distribution pattern of the various serotypes turned out to be substantially similar among the different groups of patients, subdivided on the basis of their caries status, indicating that none of the serotypes was particularly associated with dental caries.


Subject(s)
Dental Plaque/microbiology , Streptococcus mutans/classification , Adolescent , Adult , Antibodies, Monoclonal , Enzyme-Linked Immunosorbent Assay , Female , Humans , Italy , Male , Middle Aged , Prevalence , Serotyping , Streptococcus mutans/isolation & purification
20.
Dev Comp Immunol ; 16(2-3): 197-207, 1992.
Article in English | MEDLINE | ID: mdl-1499839

ABSTRACT

The activity of three enzymes involved in the salvage pathway of purine nucleosides--purine nucleoside phosphorylase (PNP), xanthine dehydrogenase (XDH), and hypoxanthine-guanine phosphoribosyl transferase (HGPRT)--was investigated in cellular fractions of the chicken bursa of Fabricius differentially enriched in epithelial cells or lymphocytes. Markedly increasing levels of PNP and XDH were observed along with the enrichment in epithelial cells together with a slight, though significant, decrease in HGPRT activity. By contrast, a dramatic fall in PNP and XDH activities was detected along with the enrichment in lymphocytes together with a slight, though significant, increase in HGPRT activity. This sharply different distribution of the three enzymes, all sharing hypoxanthine as a substrate, clearly indicates that lymphocytes preferentially channel hypoxanthine into the salvage and interconversion pathways, phosphorylating it to IMP, while epithelial cells rapidly catabolize such a purine base to uric acid. Moreover, epithelial cells, unlike lymphocytes, are able to retain high intracellular levels of both hypoxanthine and inosine. These results support the possibility that epithelial cells contribute to the normal development of bursal lymphocytes by supplying such actively proliferating cells with purine rings and at the same time by preventing them from accumulating potentially toxic high levels of purine nucleotides being able to rapidly eliminate excess hypoxanthine as uric acid from the bursa environment into the bloodstream.


Subject(s)
B-Lymphocytes/cytology , Bursa of Fabricius/growth & development , Hypoxanthine Phosphoribosyltransferase/analysis , Purine-Nucleoside Phosphorylase/analysis , Purines/metabolism , Xanthine Dehydrogenase/analysis , Animals , B-Lymphocytes/enzymology , Bursa of Fabricius/cytology , Bursa of Fabricius/metabolism , Cell Count , Cell Separation , Chickens/growth & development , Chickens/metabolism , Epithelial Cells , Epithelium/enzymology , Hypoxanthine , Hypoxanthines/metabolism , Inosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...